common.study.topics.clinical

Novel Oropharyngeal Airway

common.study.values.description

Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway

Guedel pattern or oropharyngeal airways (OPA) maintain an open oral airway in unconscious or semi-conscious patients by preventing the tongue from covering the epiglottis, but OPA placement carries a risk of inducing gag reflex and vomiting. Although various sizes are available, the design of the OPA has undergone little change since its introduction in the 1920s. The purpose of this study is to determine the utility of a novel airway device, the ManMaxAirway (MMA), as an alternative to the OPA.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - ManMaxAirway oropharyngeal airway adjunct

Healthy volunteers will self-place the ManMaxAirway.

Device - Guedel Oropharyngeal airway adjunct

Healthy volunteers will self-place the standard Guedel OPA.

Device - No airway adjunct

Healthy volunteers will have no airway adjunct in place.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway

common.study.values.clinical-trial-id

NCT03969147

participant.views.study.view.id

aOYDRd